Finance

Lists
Why is KROS down १२.७४%?
Dive Deeper
KROS:NASDAQ
Keros Therapeutics Inc
US$ ९.४५
-१२.७४%
(-१.३८) 1D
नोभेम्बर ५, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KROS...
Open
US$ १०.८४
High
US$ १०.९८
Low
US$ ९.३७
Mkt. cap
१८.७४ करोड
Avg. vol.
१.६७ लाख
Volume
२.३८ लाख
52-wk high
US$ २२.५५
52-wk low
US$ ९.३७
EPS
-US$ ३.७०
Beta
१.१३
Shares outstanding
१.९८ करोड
No. of employees
९२
Open
US$ १०.८४
High
US$ १०.९८
Low
US$ ९.३७
Mkt. cap
१८.७४ करोड
Avg. vol.
१.६७ लाख
Volume
२.३८ लाख
52-wk high
US$ २२.५५
52-wk low
US$ ९.३७
EPS
-US$ ३.७०
Beta
१.१३
Shares outstanding
१.९८ करोड
No. of employees
९२
News stories
From web sources and news partners
About Keros Therapeutics Inc
CEO-
Employees९२
Founded२०१५
HeadquartersLexington, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitekerostx.com
Analyst ratings
Based on 2 analysts giving stock ratings to KROS in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for KROS in the last 3 months.
Highest
Current US$ ९.४५
US$ १८.०० (+९०.४८%)
Average
US$ १७.५० (+८५.१९%)
Lowest
US$ १७.०० (+७९.८९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Benjamin Burnett
Wells Fargo
Buy
Maintained
US$ १८.००
+९०.५%
09/02/2026
Jason Zemansky
Bank of America Securities
Hold
Reiterated
US$ १७.००
+७९.९%
08/11/2026
Yun Zhong
Wedbush
Hold
Maintained
US$ १६.००
+६९.३%
08/04/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
US$ २०.००
+१११.६%
08/04/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
08/04/2026
Thomas Smith
Leerink Partners
Buy
Maintained
US$ २३.००
+१४३.४%
08/04/2026
Nicholas Lorusso
TD Cowen
Hold
Reiterated
-
-
08/04/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
-
-
05/15/2026
Andreas Argyrides
Oppenheimer
Buy
Maintained
US$ २७.००
+१८५.७%
03/09/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
US$ ३०.००
+२१७.५%
03/06/2026
Tiago Fauth
Raymond James
Buy
Maintained
US$ २०.००
+१११.६%
03/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.४३ करोड
३.८५ लाख
३.६७ लाख
-
Cost of goods sold
१.९५ करोड
१.७८ करोड
१.६१ करोड
२.२३ करोड
Cost of revenue
१.९५ करोड
१.७८ करोड
१.६१ करोड
२.२३ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.०१ करोड
१.१७ करोड
१.०१ करोड
८६.०६ लाख
Operating expense
१.०१ करोड
१.१७ करोड
१.०१ करोड
८६.०६ लाख
Total operating expenses
२.९६ करोड
२.९६ करोड
२.६२ करोड
३.०९ करोड
Operating income
-१.५४ करोड
-२.९२ करोड
-२.५९ करोड
-३.०९ करोड
Other non operating income
-
-५.३९ लाख
-
-६०.०० हजार
EBT including unusual items
-८७.०४ लाख
-२.५० करोड
-२.३७ करोड
-२.८७ करोड
EBT excluding unusual items
-८७.०४ लाख
-२.४९ करोड
-२.३७ करोड
-२.८७ करोड
Income tax expense
-१४.२४ लाख
-१५.१४ लाख
-
-
Effective tax rate
१६.३६%
६.०६%
-
-
Other operating expenses
-
-
-
-
Net income
-७२.८० लाख
-२.३५ करोड
-२.३७ करोड
-२.८७ करोड
Net profit margin
-५१.०४%
-६,०९३.७७%
-६,४५९.९५%
-
Earnings per share
-०.१८
-०.८६
-१.२१
-१.४५
Interest and investment income
६९.३३ लाख
४०.२२ लाख
२३.३५ लाख
२२.८७ लाख
Interest expense
-
-
-
-
Net interest expenses
६९.३३ लाख
४०.२२ लाख
२३.३५ लाख
२२.८७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.५० करोड
-२.८८ करोड
-२.५५ करोड
-३.०५ करोड
Gain or loss from assets sale
-
१.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू